tirzepatide icer They are used in combination with diet and exercise to help lower blood sugar levels in patients with type 2 diabetes FDA approves tirzepatide, Eli Lilly's

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that can lead to substantial weight loss

Remarkably, 63% of participants in the highest dose group achieved 20% weight loss

This does not guarantee perfection, but it does mean the product has passed quantitative testing before reaching you

They found mean HbA1c reductions from baseline of up to 2.46% and mean weight reductions of up to 13.1 kg with the highest dose of tirzepatide

Weight Loss Results In the landmark SURMOUNT-1 trial, participants without diabetes achieved jaw-dropping weight loss results averaging 15-20% of their body weight over 72 weeks

I wont order from any other pharmacy